Effects of Talampanel on Patients With Advanced Parkinson's Disease
- Study Title
- Effects of Talampanel on Patients With Advanced Parkinson's Disease
- Teva Identifier
- IXL-202-18-189
- ClinicalTrials.gov Identifier
- NCT00036296
- Study Status
- Completed
- Trial Condition(s)
- Dyskinesias | Parkinson Disease | Movement Disorders
- Interventions
- Drug: talampanel
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 40 Years to 85 Years
- Trial Duration
- 12/01/2006 - 02/01/2007
- Phase
- Phase 1/2